secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001104659-23-060945
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp enters additional non-redemption deals covering 1.5M shares ahead of extension vote
--------------------------------------------------------------------------------

- Non-redemption agreements with unaffiliated third parties on May 9 and May 12, 2023 covering 1,500,000 Class A shares.
- In exchange, Sponsor transfers 750,000 Class B shares to those investors after a business combination.
- Shares remain in trust after Extraordinary General Meeting; extension proposal seeks to push deadline to May 2024.
- Agreements are not expected to affect approval likelihood but will increase trust account funds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923060945/0001104659-23-060945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000110465923060945/tm2315876d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-060945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer